What has been revealed in the “Remdesivir Papers” will shock you to the core.
This compilation of documents, released by a military whistleblower, contains damning information on the hundreds of deaths and adverse events related to the clinical trials of a COVID antiviral.
Besides the compromise on the fundamental issue of informed consent, these files reveal concerning truths related to the methodology and processing of the product testing data among servicemembers.
Brad Miller gives viewers an in-depth analysis of this subject matter on “Defender In-Depth.”
The evidence presented in the video is of utmost significance.
Our thoughts are with Service Members, victims of Remdesevir.
“Writing for American Thinker, author Stella Paul once said, “Remdesivir may be the most despised drug in American history, earning the nickname ‘Run Death Is Near’ for its lethal record during COVID.”1
The Remdesivir Papers captures the essence of her statement for service members and veterans across the country.”
***
The Mystery of Banking
Best Price: $2.23
Buy New $7.57
(as of 07:55 UTC - Details)
The fraud was known from the very outset when Remdesevir was launched in the months following the March 2020 Lockdown.
No action was taken to withdraw Remdesevir produced by Gilead Sciences Inc a Company which was headed Donald Rumsfeld (1997-2001), who became Secretary of Defense (2001-2006) under the GWB administration
Prof. Michel Chossudovsky’s July 5, 2020 was article entitled:
LancetGate: “Scientific Corona Lies” and Big Pharma Corruption. Hydroxychloroquine versus Gilead’s Remdesivir
focussed on the suppression of hydroxychloroquine (HCQ) while promoting Remdesivir
“The studies respectively on Gilead Science’s Remdesivir and hydroxychloroquine (HCQ) were conducted simultaneously by Brigham and Women’s Hospital (BWH)”. Was there a conflict of interest.
Below is a revised version of the article published in Professor Chossudovsky’s eBook.
Corrupt Science: “There Is No Cure”
Suppression of Hydroxychloroquine (HCQ), A Cheap and Effective Drug
from the eBook, The Worldwide Corona Crisis. Global Coup d’Etat Against Humanity by Prof. Michel Chossudovsky
The book is available in pdf. You can download it for free, click here (docsend).
ISBN: 978-0-9879389-3-0, Year: 2022, PDF Ebook, Pages: 164, 15 Chapters
There was an ongoing battle to suppress hydroxychloroquine (HCQ), a cheap and effective drug for the treatment of COVID-19. The campaign against HCQ was carried out through slanderous political statements, media smears, not to mention an authoritative peer-reviewed “evaluation” published on May 22 by The Lancet, which was based on fake figures and test trials.
The study was allegedly based on data analysis of 96,032 patients hospitalized with COVID-19 between Dec 20, 2019, and April 14, 2020 from 671 hospitals worldwide. The database had been fabricated. The objective was to kill the hydroxychloroquine (HCQ) cure on behalf of Big Pharma.
While The Lancet article was retracted, the media casually blamed “a tiny US-based company” named Surgisphere whose employees included “a sci-fi writer and adult content model” for spreading “flawed data” (Guardian). This Chicago-based outfit was accused of having misled both the WHO and national governments, inciting them to ban HCQ. None of those trial tests actually took place.
Screenshot from The Lancet
.
While the blame was placed on Surgisphere, the unspoken truth (which neither the scientific community nor the media has acknowledged) is that the study was coordinated by Harvard professor Mandeep Mehra under the auspices of Brigham and Women’s Hospital (BWH), which is a partner of the Harvard Medical School.
When the scam was revealed, Dr. Mandeep Mehra, who holds the Harvey Distinguished Chair of Medicine at Brigham and Women’s Hospital, apologized:
“I have always performed my research in accordance with the highest ethical and professional guidelines. However, we can never forget the responsibility we have as researchers to scrupulously ensure that we rely on data sources that adhere to our high standards.
It is now clear to me that in my hope to contribute this research during a time of great need, I did not do enough to ensure that the data source was appropriate for this use. For that, and for all the disruptions – both directly and indirectly – I am truly sorry.” (emphasis added)
Mandeep R. Mehra, MD, MSC (official statement on BWH website)1
But that “truly sorry” note was just the tip of the iceberg. Why?
The studies respectively on Gilead Sciences’ remdesivir and on hydroxychloroquine (HCQ) were conducted simultaneously by Brigham and Women’s Hospital (BWH).
While The Lancet report (May 22, 2020) coordinated by Dr. Mandeep Mehra was intended “to kill” the legitimacy of HCQ as a cure of COVID-19, another important (related) study was being carried out (concurrently) at BWH pertaining to remdesivir on behalf of Gilead Sciences, Inc.
Dr. Francisco Marty, a specialist in Infectious Disease and Associate Professor at Harvard Medical School, was entrusted with coordination of the clinical trial tests of the antiviral medication remdesivir under Brigham’s contract with Gilead Sciences, Inc2:
“Brigham and Women’s Hospital began enrolling patients in two clinical trials for Gilead’s antiviral medication remdesivir. The Brigham is one of multiple clinical trial sites for a Gilead-initiated study of the drug in 600 participants with moderate coronavirus disease (COVID-19) and a Gilead-initiated study of 400 participants with severe COVID-19.
… If the results are promising, this could lead to FDA approval, and if they aren’t, it gives us critical information in the fight against COVID-19 and allows us to move on to other therapies.”
While Dr. Mandeep Mehra was not directly involved in the Gilead Remdesivir BWH study under the supervision of his colleague Dr. Francisco Marty, he nonetheless had contacts with Gilead Sciences, Inc:
Breaking Away: The Cas...
Best Price: $6.14
Buy New $12.00
(as of 04:46 UTC - Details)
“He participated in a conference sponsored by Gilead in early April 2020 as part of the Covid-19 debate” (France Soir, May 23, 2020)3
What was the intent of his (failed) study? To undermine the legitimacy of hydroxychloroquine?
According to France Soir, in a report published after The Lancet retraction:
The often evasive answers produced by Dr Mandeep R. Mehra, … professor at Harvard Medical School, did not produce confidence, fueling doubt instead about the integrity of this retrospective study and its results. (France Soir, June 5, 2020)4
Was Dr. Mandeep Mehra in conflict of interest? (That is a matter for BWH and the Harvard Medical School to decide upon)
